SARS-CoV-2 viral dynamics in non-human primates

Author:

Gonçalves AntonioORCID,Maisonnasse PaulineORCID,Donati FloraORCID,Albert MélanieORCID,Behillil SylvieORCID,Contreras Vanessa,Naninck ThibautORCID,Marlin RomainORCID,Solas CarolineORCID,Pizzorno AndresORCID,Lemaitre JulienORCID,Kahlaoui NidhalORCID,Terrier OlivierORCID,Ho Tsong Fang RaphaelORCID,Enouf Vincent,Dereuddre-Bosquet Nathalie,Brisebarre Angela,Touret FranckORCID,Chapon CatherineORCID,Hoen Bruno,Lina Bruno,Rosa Calatrava Manuel,de Lamballerie XavierORCID,Mentré FranceORCID,Le Grand RogerORCID,van der Werf Sylvie,Guedj JérémieORCID

Abstract

Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>104 virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.

Funder

Agence Nationale de la Recherche

Bill and Melinda Gates Foundation

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modelling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference32 articles.

1. Weekly epidemiological update—22 December 2020. [cited 11 Jan 2021]. Available: https://www.who.int/publications/m/item/weekly-epidemiological-update—22-december-2020

2. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population;N Lapidus;Infect Dis Now,2021

3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;N Chen;The Lancet,2020

4. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;X Yang;The Lancet Respiratory Medicine,2020

5. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications;F Wu;medRxiv,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3